NCT04535687View on ClinicalTrials.gov

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

June 12, 2023

Study Completion Date

June 12, 2023

Conditions
Renal Cell Carcinoma
Interventions
DRUG

Fluzoparib

Fluzoparib

Trial Locations (1)

210000

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

NCT04535687 - Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter